Search Results
Treating Early HER2+ Breast Cancer: KRISTINE
Adjuvant TDM-1 and the KRISTINE Trial
Dr. Westbrook on 3-Year Follow-Up Data of the KRISTINE Trial in HER2+ Breast Cancer
Kristine: Breast Cancer
PREDICT+ underestimates survival of patients with HER2+ early breast cancer
Getting Through Breast Cancer with a Smile - Christine's Journey
Neoadjuvant T-DM1 in Early-Stage HER2+ Breast Cancer
Neoadjuvant T-DM1 in HER2+ Early Breast Cancer
Understanding and Treating HER2+ Breast Cancer
How Treatment for HER2+ Breast Cancer has Changed
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg
How Clinical Trials Can Treat Metastatic Breast Cancer | Christine Hodgdon
